Resultados da busca - Irene Virgolini

Refinar Resultados
  1. 1
    Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and Alternatives

    Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors: Agonist, Antagonist and Alternatives por Giulia Santo, Gianpaolo di Santo, Irene Virgolini

    Publicado em 2024
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  2. 2
    Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy

    Twelve-Year Follow-up After Peptide Receptor Radionuclide Therapy por Michael Gabriel, Bernhard Nilica, Bernhard Kaiser, Irene Virgolini

    Publicado em 2018
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  3. 3
    Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023

    Peptide receptor radionuclide therapy combinations for neuroendocrine tumours in ongoing clinical trials: status 2023 por Gianpaolo di Santo, Giulia Santo, Anna Sviridenko, Irene Virgolini

    Publicado em 2024
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  4. 4
    Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors

    Peptide receptor radionuclide therapy with somatostatin analogs beyond gastroenteropancreatic neuroendocrine tumors por Giulia Santo, Gianpaolo di Santo, Francesco Cicone, Irene Virgolini

    Publicado em 2025
    Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  5. 5
    Current status of theranostics in prostate cancer

    Current status of theranostics in prostate cancer por Irene Virgolini, Clemens Decristoforo, Alexander Haug, Stefano Fanti, Christian Uprimny

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  6. 6
    Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study

    Pediatric reference intervals for thyroid hormone levels from birth to adulthood: a retrospective study por Klaus Kapelari, Christine Kirchlechner, Wolfgang Högler, Katharina Schweitzer, Irene Virgolini, Roy Moncayo

    Publicado em 2008
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  7. 7
    [68Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis

    [68Ga]NODAGA-RGD – Metabolic stability, biodistribution, and dosimetry data from patients with hepatocellular carcinoma and liver cirrhosis por Roland Haubner, Armin Finkenstedt, Armin Stegmayr, Christine Rangger, Clemens Decristoforo, Heinz Zoller, Irene Virgolini

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  8. 8
    Left hemispheric predominance of nigrostriatal dysfunction in Parkinson’s disease

    Left hemispheric predominance of nigrostriatal dysfunction in Parkinson’s disease por Christoph Scherfler, Klaus Seppi, Katherina Mair, Eveline Donnemiller, Irene Virgolini, Gregor K. Wenning, Werner Poewe

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  9. 9
    Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review

    Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review por Finn Edler von Eyben, Giandomenico Roviello, Timo Kiljunen, Christian Uprimny, Irene Virgolini, Kalevi Kairemo, Timo Joensuu

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Revisão
    Salvar na lista
    Na minha lista:
  10. 10
    Response of Recurrent High-Grade Glioma to Treatment with <sup>90</sup>Y-DOTATOC

    Response of Recurrent High-Grade Glioma to Treatment with <sup>90</sup>Y-DOTATOC por Dirk Heute, H. Kostron, Elisabeth von Guggenberg, Shota Ingorokva, Michael Gabriel, Georg Dobrozemsky, Günther Stockhammer, Irene Virgolini

    Publicado em 2010
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  11. 11
    Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer

    Preliminary Clinical Experience with Cholecystokinin-2 Receptor PET/CT Using the<sup>68</sup>Ga-Labeled Minigastrin Analog DOTA-MGS5 in Patients with Medullary Thyroid Cancer por Elisabeth von Guggenberg, Christian Uprimny, Maximilian Klinger, Boris Warwitz, Anna Sviridenko, Steffen Bayerschmidt, Gianpaolo di Santo, Irene Virgolini

    Publicado em 2023
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  12. 12
    DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

    DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use por Maximilian Klingler, Dominik Summer, Christine Rangger, Roland Haubner, Julie Foster, Jane Sosabowski, Clemens Decristoforo, Irene Virgolini, Elisabeth von Guggenberg

    Publicado em 2018
    Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  13. 13
    Bone Metastases in Patients with Neuroendocrine Tumor: <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET in Comparison to CT and Bone Scintigraphy

    Bone Metastases in Patients with Neuroendocrine Tumor: <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET in Comparison to CT and Bone Scintigraphy por Daniel Putzer, Michael Gabriel, Benjamin Henninger, Dorota Kendler, Christian Uprimny, Georg Dobrozemsky, Clemens Decristoforo, Reto Bale, Werner Jaschke, Irene Virgolini

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  14. 14
    <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy

    <sup>68</sup>Ga-DOTA-Tyr<sup>3</sup>-Octreotide PET for Assessing Response to Somatostatin-Receptor–Mediated Radionuclide Therapy por Michael Gabriel, Andreas Oberauer, Georg Dobrozemsky, Clemens Decristoforo, Daniel Putzer, Dorota Kendler, Christian Uprimny, Péter Kovács, Reto Bale, Irene Virgolini

    Publicado em 2009
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  15. 15
    68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT

    68Ga-DOTA-Tyr3-Octreotide PET in Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and CT por Michael Gabriel, Clemens Decristoforo, Dorota Kendler, Georg Dobrozemsky, Dirk Heute, Christian Uprimny, Péter Kovács, Elisabeth von Guggenberg, Reto Bale, Irene Virgolini

    Publicado em 2007
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  16. 16
    Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme

    Persistent quality of life impairments in differentiated thyroid cancer patients: results from a monitoring programme por Eva‐Maria Gamper, Lisa M. Wintner, Margarida Rodrigues, Sabine Buxbaum, Bernhard Nilica, Susanne Singer, Johannes M. Giesinger, Bernhard Holzner, Irene Virgolini

    Publicado em 2015
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  17. 17
    Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification

    Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification por Alexander Kroiss, Daniel Putzer, Christian Uprimny, Clemens Decristoforo, Michael Gabriel, Wolfram Santner, Christof Kranewitter, Boris Warwitz, Dietmar Waitz, Dorota Kendler, Irene Virgolini

    Publicado em 2012
    Obter o texto integral Obter o texto integral
    Carta
    Salvar na lista
    Na minha lista:
  18. 18
    Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycle

    Direct comparison of 68Ga-DOTA-TOC and 18F-FDG PET/CT in the follow-up of patients with neuroendocrine tumour treated with the first full peptide receptor radionuclide therapy cycl... por Bernhard Nilica, Dietmar Waitz, Vlado Stevanovic, Christian Uprimny, Dorota Kendler, Sabine Buxbaum, Boris Warwitz, Llanos Gerardo, Benjamin Henninger, Irene Virgolini, Margarida Rodrigues

    Publicado em 2016
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  19. 19
    The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates

    The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates por Lorenza Scarpa, Sabine Buxbaum, Dorota Kendler, Katharina Fink, Jasmin Bektić, Leonhard Gruber, Clemens Decristoforo, Christian Uprimny, Peter Lukáš, Wolfgang Horninger, Irene Virgolini

    Publicado em 2017
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:
  20. 20
    Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors

    Vasoactive Intestinal Peptide-Receptor Imaging for the Localization of Intestinal Adenocarcinomas and Endocrine Tumors por Irene Virgolini, Markus Raderer, Amir Kurtaran, P. Angelberger, S. Banyai, Qiong Yang, Shuren Li, Martin Banyai, Johann Pidlich, Bruno Niederle, Werner Scheithauer, Peter Valent

    Publicado em 1994
    Obter o texto integral Obter o texto integral
    Artigo
    Salvar na lista
    Na minha lista:

Ferramentas de busca: